| PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib (NCT02389842) | Royal Marsden NHS Foundation Trust | 2015-03-25 |
| Electromagnetic Navigation for Peripheral Pulmonary Lesions (NCT02582944) | Washington University School of Medicine | 2015-03-25 |
| Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) (NCT03113747) | A.A. Partners, LLC | 2015-03-25 |
| Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment (NCT02397707) | Gilead Sciences | 2015-03-24 |
| Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) (NCT02368951) | Bayer | 2015-03-24 |
| A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma (NCT02383368) | Astellas Pharma Global Development, Inc. | 2015-03-23 |
| Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia (NCT03455335) | National University of Ireland, Galway, Ireland | 2015-03-23 |
| A Study of Olaratumab in Japanese Participants With Advanced Cancer (NCT02377752) | Eli Lilly and Company | 2015-03-23 |
| Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart (NCT02462161) | Wake Forest University Health Sciences | 2015-03-20 |
| The ONE Study ATDC Trial (NCT02252055) | Nantes University Hospital | 2015-03-19 |
| Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors (NCT02345174) | GlaxoSmithKline | 2015-03-19 |
| Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors (NCT02367352) | Millennium Pharmaceuticals, Inc. | 2015-03-19 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function (NCT02412098) | Gilead Sciences | 2015-03-19 |
| A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) (NCT02332668) | Merck Sharp & Dohme LLC | 2015-03-19 |
| Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients (NCT02643862) | Stanford University | 2015-03-18 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers (NCT02413255) | Takeda | 2015-03-18 |
| Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma (NCT02308553) | Prof. Dr. med. Dirk Schadendorf | 2015-03-17 |
| Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route (NCT02449174) | The University of Texas Health Science Center, Houston | 2015-03-17 |
| Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma (NCT02327390) | Case Comprehensive Cancer Center | 2015-03-17 |
| A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer (NCT02316509) | Genentech, Inc. | 2015-03-17 |
| Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies (NCT02398747) | AstraZeneca | 2015-03-17 |
| Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease (NCT02551614) | GlaxoSmithKline | 2015-03-17 |
| Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors (NCT02271711) | M.D. Anderson Cancer Center | 2015-03-17 |
| CKD-337(2) Drug-drug Interaction Study (NCT02422030) | Chong Kun Dang Pharmaceutical | 2015-03-17 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer (NCT02392611) | Gilead Sciences | 2015-03-16 |
| Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer (NCT02048150) | City of Hope Medical Center | 2015-03-13 |
| Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma (NCT02343172) | Novartis Pharmaceuticals | 2015-03-13 |
| Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection (NCT02363322) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-13 |
| FBnTP Imaging of Breast Cancer (NCT02204462) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-12 |
| The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012) (NCT02336555) | Merck Sharp & Dohme LLC | 2015-03-12 |
| A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers (NCT02367196) | Celgene | 2015-03-12 |
| Effect of Fenugreek Use in Mothers of Preterm on Breast Milk Production and Macronutrient Content (NCT02384655) | Tel-Aviv Sourasky Medical Center | 2015-03-11 |
| Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML (NCT01849276) | Northwestern University | 2015-03-11 |
| Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers (NCT02389192) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-11 |
| [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer (NCT02284919) | University of Pennsylvania | 2015-03-11 |
| Single-dose PK Study of Benapenem In Healthy Subjects (NCT03588156) | Sihuan Pharmaceutical Holdings Group Ltd. | 2015-03-11 |
| An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T) (NCT02225574) | M.D. Anderson Cancer Center | 2015-03-11 |
| Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase (NCT02258607) | Sierra Oncology LLC - a GSK company | 2015-03-11 |
| A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies (NCT02329847) | Janssen Research & Development, LLC | 2015-03-11 |
| Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer (NCT02317016) | AstraZeneca | 2015-03-10 |
| Cambridge Brain Mets Trial 1 (NCT02768337) | Cambridge University Hospitals NHS Foundation Trust | 2015-03-10 |
| Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML) (NCT02323113) | Calithera Biosciences, Inc | 2015-03-09 |
| Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b (NCT02339324) | Yana Najjar | 2015-03-06 |
| Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer (NCT02458716) | Rutgers, The State University of New Jersey | 2015-03-06 |
| C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810) | Eastern Cooperative Oncology Group | 2015-03-06 |
| CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors (NCT02401815) | Cogent Biosciences, Inc. | 2015-03-06 |
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations (NCT02381886) | Novartis Pharmaceuticals | 2015-03-06 |
| Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma (NCT02280525) | M.D. Anderson Cancer Center | 2015-03-05 |
| Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer (NCT02164461) | Advaxis, Inc. | 2015-03-04 |
| Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants (NCT02426632) | Janssen Sciences Ireland UC | 2015-03-04 |
| Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy (NCT02237196) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-03 |
| Study of TCP-ATRA for Adult Patients With AML and MDS (NCT02273102) | University of Miami | 2015-03-02 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer (NCT02390739) | National Cancer Institute (NCI) | 2015-03-02 |
| A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors (NCT02318394) | MedImmune LLC | 2015-03-02 |
| Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women (NCT02377414) | GlaxoSmithKline | 2015-03-02 |
| PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects (NCT02387866) | Celgene | 2015-03-02 |
| A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users (NCT02413281) | Alkermes, Inc. | 2015-03-01 |
| Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela (NCT02283879) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2015-03-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia (NCT02411695) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-03-01 |
| A Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA of AZD0585 in Healthy Male Japanese Subjects (NCT02372344) | AstraZeneca | 2015-03-01 |
| Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule (NCT02382640) | Takeda | 2015-03-01 |
| Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects (NCT02418650) | Orion Corporation, Orion Pharma | 2015-03-01 |
| A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment (NCT02387814) | Eli Lilly and Company | 2015-03-01 |
| Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients (NCT02411825) | Sanofi | 2015-03-01 |
| A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors (NCT02403271) | Pharmacyclics LLC. | 2015-03-01 |
| Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects (NCT02397005) | Zai Lab Pty. Ltd. | 2015-03-01 |
| Bioequivalence Study of Idalopirdine Tablets 60 mg (NCT02371707) | H. Lundbeck A/S | 2015-03-01 |
| Comparison Study of PF530 and Betaferon in Healthy Subjects (NCT02474134) | Pfenex, Inc | 2015-03-01 |
| Microendoscopic Discectomy Vs Transforaminal Endoscopic Lumbar Discectomy Vs Open Discectomy (NCT02358291) | Southeast University, China | 2015-03-01 |
| Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer (NCT02384850) | GSO Global Clinical Research BV | 2015-03-01 |
| A Website to Teach Children Safety With Dogs (NCT02299427) | University of Alabama at Birmingham | 2015-03-01 |
| Investigator Initiated Phase 1 Study of TBI-1301 (NCT02366546) | Mie University | 2015-03-01 |
| Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus (NCT03265197) | saad elzayat | 2015-03-01 |
| A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets (NCT02372097) | Takeda | 2015-03-01 |
| Clinical Trial to Evaluate the Potential Efficacy and Safety of Human Umbilical Cord Blood and Plasma (NCT02418013) | Bundang CHA Hospital | 2015-03-01 |
| Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population (NCT02486744) | Youngstown State University | 2015-03-01 |
| Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands (NCT02203825) | Celyad Oncology SA | 2015-03-01 |
| Transversus Abdominis Plane Versus Caudal Block for Pediatrics (NCT02398123) | Mansoura University | 2015-03-01 |
| Project 4A: Inspiratory Muscle Training and Diaphragm Strength (NCT02367170) | University of Florida | 2015-03-01 |
| A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne (NCT02404285) | Next Science TM | 2015-03-01 |
| Description of Pain in Pediatric Patients With Cleft Lip and Palate Undergoing Alveolar Grafting Using Two Surgical Strategies: Stem Cells and Autogenous Iliac Crest Bone (Pain Evaluation in Children Undergoing Alveolar Grafting: Stem Cells vs. Iliac Crest Bone) (NCT07734974) | Hospital Sirio-Libanes | 2015-03-01 |
| Anti-GPC3 CAR T for Treating Patients With Advanced HCC (NCT02395250) | RenJi Hospital | 2015-03-01 |
| Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women (NCT02357602) | University of North Carolina, Chapel Hill | 2015-03-01 |
| MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study (NCT02427178) | Michio Hirano, MD | 2015-03-01 |
| The Effect of Cysteine, Tryptophan and Tyrosine Supplements on Breast Milk (NCT02462746) | Centre for Addiction and Mental Health | 2015-03-01 |
| Evaluation of Metabolic Profile of OC000459 (NCT02341521) | Atopix Therapeutics, Ltd. | 2015-03-01 |
| A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT02367066) | AstraZeneca | 2015-03-01 |
| Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults (NCT02771730) | Emergent BioSolutions | 2015-03-01 |
| Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model (NCT02666846) | Futura Medical Developments Ltd. | 2015-03-01 |
| An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B (NCT02213250) | Pfizer | 2015-03-01 |
| Pulmonary Protection of Transcutaneous Electrical Acupoint Stimulation in Gynecologic Laparoscopic Surgery (NCT02850471) | Shengjing Hospital | 2015-03-01 |
| Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer (NCT02305186) | Craig L Slingluff, Jr | 2015-03-01 |
| Feasibility Trial of CBT for Depersonalisation in Psychosis (NCT02427542) | King's College London | 2015-03-01 |
| A Preliminary Study About Unexplained Recurrent Miscarriage and Repeated Implantation Failure Patients Treated With Low-dose Lymphocyte Immunotherapy (NCT03081325) | Nanjing University | 2015-03-01 |
| Gene Therapy for the Treatment of Chronic Stable Angina (NCT01002495) | Helixmith Co., Ltd. | 2015-03-01 |
| Freeze-dried, Capsulized FMT for RCDI (NCT02399618) | Jinling Hospital, China | 2015-03-01 |
| Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride (NCT02263547) | Derrick Scott Robertson | 2015-03-01 |
| A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin (NCT02392130) | LEO Pharma | 2015-03-01 |
| Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants (NCT02396147) | Takeda | 2015-03-01 |
| A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects (NCT02391623) | Pfizer | 2015-03-01 |